Scilex (SCLX) News Today $1.68 -0.02 (-1.18%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 2:57 AM | americanbankingnews.comScilex (NASDAQ:SCLX) Trading Down 0.6%July 26 at 2:55 AM | marketbeat.comScilex (NASDAQ:SCLX) Shares Down 0.6% Scilex (NASDAQ:SCLX) Stock Price Down 0.6%July 24 at 10:52 AM | globenewswire.comScilex Holding Company Announces Publication of Its Inaugural Sustainability ReportJuly 3, 2024 | benzinga.comNon-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ DebutJuly 2, 2024 | globenewswire.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business CombinationJuly 2, 2024 | globenewswire.comScilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New YorkJune 20, 2024 | globenewswire.comScilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.June 17, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Scilex (NASDAQ:SCLX)HC Wainwright reaffirmed a "buy" rating and set a $7.00 target price on shares of Scilex in a research note on Monday.June 14, 2024 | globenewswire.comScilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)June 13, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Coverage Initiated by Analysts at Rodman & RenshawRodman & Renshaw assumed coverage on shares of Scilex in a research note on Thursday. They issued a "buy" rating and a $13.00 target price for the company.June 11, 2024 | globenewswire.comScilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio CompaniesJune 11, 2024 | globenewswire.comScilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®June 10, 2024 | globenewswire.comScilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.June 6, 2024 | globenewswire.comScilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024May 30, 2024 | globenewswire.comScilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding CompanyMay 27, 2024 | marketbeat.comQ2 2024 EPS Estimates for Scilex Holding (NASDAQ:SCLX) Decreased by AnalystScilex Holding (NASDAQ:SCLX - Free Report) - Analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Scilex in a research report issued on Thursday, May 23rd. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of ($0.1May 25, 2024 | finance.yahoo.comNews Flash: 3 Analysts Think Scilex Holding Company (NASDAQ:SCLX) Earnings Are Under ThreatMay 24, 2024 | globenewswire.comScilex Holding Company Announces it has been Added to the MSCI Global Microcap IndexMay 24, 2024 | marketbeat.comBrokers Set Expectations for Scilex Holding's Q4 2025 Earnings (NASDAQ:SCLX)Scilex Holding (NASDAQ:SCLX - Free Report) - Equities researchers at HC Wainwright reduced their Q4 2025 earnings estimates for Scilex in a research report issued on Thursday, May 23rd. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.01) per share for the quarter, doMay 24, 2024 | globenewswire.comScilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding CompanyMay 23, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Price Target Lowered to $7.00 at HC WainwrightHC Wainwright decreased their price objective on Scilex from $8.00 to $7.00 and set a "buy" rating on the stock in a research report on Thursday.May 22, 2024 | finance.yahoo.comWith Scilex Holding Up 36%, Insider Buyers Count Their ReturnsMay 18, 2024 | insidertrades.comScilex Holding (NASDAQ:SCLX) Director Purchases $51,750.00 in StockMay 17, 2024 | marketbeat.comScilex Holding (NASDAQ:SCLX) Director Jay Chun Purchases 57,500 SharesScilex Holding (NASDAQ:SCLX - Get Free Report) Director Jay Chun bought 57,500 shares of the business's stock in a transaction on Friday, May 17th. The stock was purchased at an average cost of $0.90 per share, for a total transaction of $51,750.00. Following the transaction, the director now owns 102,500 shares of the company's stock, valued at $92,250. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.May 14, 2024 | msn.comSCLX Grows Revenue and Expands PortfolioMay 14, 2024 | msn.comScilex wins court approval for Takeda settlementMay 14, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Stock Price Up 0.2%Scilex (NASDAQ:SCLX) Shares Up 0.2%May 14, 2024 | msn.comSCLX Stock Earnings: Scilex Holding Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | finance.yahoo.comScilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®May 13, 2024 | globenewswire.comScilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common StockMay 10, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Trading Down 5.9%Scilex (NASDAQ:SCLX) Shares Down 5.9%May 9, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Stock Price Down 0.9%Scilex (NASDAQ:SCLX) Trading Down 0.9%May 3, 2024 | markets.businessinsider.comMaintaining Buy Rating on Scilex: Strategic and Financial Optimism Despite ChallengesApril 26, 2024 | investing.comScilex secures $15 million in registered direct offeringApril 25, 2024 | globenewswire.comScilex Holding Company Announces Closing of $15 Million Registered Direct OfferingApril 24, 2024 | globenewswire.comScilex Holding Company Announces $15 Million Registered Direct OfferingApril 16, 2024 | msn.comScilex to reduce R&D expenses in 2024, comments on actions post Change Healthcare cyberattackApril 16, 2024 | globenewswire.comScilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative ExpensesApril 9, 2024 | globenewswire.comScilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing PoolMarch 27, 2024 | globenewswire.comScilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a DividendMarch 21, 2024 | globenewswire.comScilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured PatientsMarch 20, 2024 | globenewswire.comScilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is NeededMarch 20, 2024 | globenewswire.comScilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®March 19, 2024 | msn.comScilex Holding repays the remaining balance of convertible debenturesMarch 19, 2024 | globenewswire.comScilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationMarch 18, 2024 | globenewswire.comScilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in CanadaMarch 16, 2024 | finance.yahoo.comSCLX Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comSCLX Apr 2024 1.000 putMarch 15, 2024 | globenewswire.comScilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.March 15, 2024 | markets.businessinsider.comScilex Pharma Enters Definitive Mutual Release And Settlement Agreement With Virpax Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address The next companies to potentially benefit thanks to Nvidia are … (Ad)Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners. Click here to learn more. SCLX Media Mentions By Week SCLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCLX News Sentiment▼0.620.62▲Average Medical News Sentiment SCLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCLX Articles This Week▼42▲SCLX Articles Average Week Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MKTW News SANA News FDMT News VIR News AUTL News RLAY News CGEM News IMTX News TARS News HUMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCLX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.